Epstein Secrets

a Cons already assumes generic competition coming next year). Copaxone Litigation Timeline (from 2O Results Slidedeck) Scenario Analysis — BofAML Daniel Lundquist EFTA00820344 Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch The power of global connections"( Find all Conference Ev

mpetition coming next year). Copaxone Litigation Timeline (from 2O Results Slidedeck) Scenario Analysis — BofAML Daniel Lundquist EFTA00820344 Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch The power of global connections"( Find all Conference Events via the Following Link: https://gems.ba

assumes generic competition coming next year). Copaxone Litigation Timeline (from 2Q Results Slidedeck) Scenario Analysis — BofAML EFTA00820353 Daniel Lundquist Healthcare Specialist Sales Global Equities The power of global connectionsTM Find all Conference Events via the Following Link: https://gems.ban

mpetition coming next year). Copaxone Litigation Timeline (from 2Q Results Slidedeck) Scenario Analysis — BofAML EFTA00820353 Daniel Lundquist Healthcare Specialist Sales Global Equities The power of global connectionsTM Find all Conference Events via the Following Link: https://gems.bankofamerica.com Disclaimer:

progression-free survival, as assessed by the Independent Radiology Review Committee, in patients with ≥ 5% PD-L1 tumor expression. EFTA00822174 Daniel Lundquist Healthcare Specialist Sales Global Equities The power of global connections TM' Disclaimer: This material was prepared by Sector Specialist Sale

survival, as assessed by the Independent Radiology Review Committee, in patients with ≥ 5% PD-L1 tumor expression. EFTA00822174 Daniel Lundquist Healthcare Specialist Sales Global Equities The power of global connections TM' Disclaimer: This material was prepared by Sector Specialist Sales personnel of Merrill Lynch

or rebounding slightly off a three-year low, the first uptick since Feb but still indicating a 'Buy" 0. The indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global

htly off a three-year low, the first uptick since Feb but still indicating a 'Buy" 0. The indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global connections TM EFTA00822654

assumes generic competition coming next year). EFTA00665659 Copaxone Litigation Timeline (from 2Q Results Slidedeck) Scenario Analysis — BofAML Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States T: The power of glo

mpetition coming next year). EFTA00665659 Copaxone Litigation Timeline (from 2Q Results Slidedeck) Scenario Analysis — BofAML Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States T: The power of global connectionsTM Find all C

r rebounding slightly off a three-year low, the first =ptick since Feb but still indicating a "Buy" (). =he indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global

tly off a three-year low, the first =ptick since Feb but still indicating a "Buy" (). =he indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global =onnections" 4 EFTA_R1_0155